Vanda Pharmaceuticals Inc. (VNDA) › Total LiabilitiesVanda Pharmaceuticals Inc. (VNDA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $175.37M2011: $149.14M2012: $125.54M2013: $99.22M2014: $10.89M2015: $80.02M2016: $79.04M2017: $74.04M2018: $56.71M2019: $72.80M2020: $80.19M2021: $88.86M2022: $107.05M2023: $103.53M2024: $117.66M2025: $161.76M$161.76M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$161.76M+37.5%2024$117.66M+13.6%2023$103.53M-3.3%2022$107.05M+20.5%2021$88.86M+10.8%2020$80.19M+10.1%2019$72.80M+28.4%2018$56.71M-23.4%2017$74.04M-6.3%2016$79.04M-1.2%2015$80.02M+635.0%2014$10.89M-89.0%2013$99.22M-21.0%2012$125.54M-15.8%2011$149.14M-15.0%2010$175.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share